Artichoke(Cynara scolymus) (Leaf)
weight loss accelerates 72w 72 Weeks Average 20.9% body weight lost at 15 mg dose in SURMOUNT-1 trial Eligibility Who Qualifies BMI of 30 or higher (obesity classification) BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea No personal or family history of medullary thyroid cancer No history of multiple endocrine neoplasia syndrome type 2 Not currently pregnant, planning pregnancy, or breastfeeding No prior severe allergic reaction to tirzepatide Your Program Common Side Effects Most side effects are gastrointestinal, mild to moderate in severity, and tend to resolve as your body adjusts during the first several weeks
Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
the FDA greenlit them to treat type 2 diabetes in 2017 and 2022, respectively
This holistic approach ensures that your underlying thyroid, adrenal, and cellular health are perfectly optimized alongside your weight loss
In order to investigate, we needed to gather data to build a large cohort of individuals actively taking these drugs
